403 related articles for article (PubMed ID: 12925071)
21. Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) a comparison between two multicenter randomized phase II/III trials.
Diefenhardt M; Fleischmann M; Martin D; Hofheinz RD; Piso P; Germer CT; Hambsch P; Grützmann R; Kirste S; Schlenska-Lange A; Ghadimi M; Rödel C; Fokas E;
Radiother Oncol; 2023 Feb; 179():109455. PubMed ID: 36572280
[TBL] [Abstract][Full Text] [Related]
22. Pre-operative chemoradiotherapy in locally advanced rectal cancer.
Elsaleh H; Joseph D; Levitt M; House A; Robbins P
Aust N Z J Surg; 1999 Oct; 69(10):737-42. PubMed ID: 10527353
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
[TBL] [Abstract][Full Text] [Related]
24. Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients.
Dunst J; Semlin S; Pigorsch S; Müller AC; Reese T
Strahlenther Onkol; 2000 Sep; 176(9):416-21. PubMed ID: 11050915
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized trial comparing intravenous 5-fluorouracil and oral doxifluridine as postoperative adjuvant treatment for advanced rectal cancer.
Min JS; Kim NK; Park JK; Yun SH; Noh JK
Ann Surg Oncol; 2000 Oct; 7(9):674-9. PubMed ID: 11034245
[TBL] [Abstract][Full Text] [Related]
26. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer.
Cafiero F; Gipponi M; Peressini A; Bertoglio S; Lionetto R
J Surg Oncol; 2000 Oct; 75(2):80-8. PubMed ID: 11064385
[TBL] [Abstract][Full Text] [Related]
27. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.
Rödel C; Grabenbauer GG; Matzel KE; Schick C; Fietkau R; Papadopoulos T; Martus P; Hohenberger W; Sauer R
Dis Colon Rectum; 2000 Mar; 43(3):312-9. PubMed ID: 10733111
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
Allegra CJ; Yothers G; O'Connell MJ; Beart RW; Wozniak TF; Pitot HC; Shields AF; Landry JC; Ryan DP; Arora A; Evans LS; Bahary N; Soori G; Eakle JF; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Sharif S; Roh MS; Wolmark N
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374429
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel C; Liersch T; Becker H; Fietkau R; Hohenberger W; Hothorn T; Graeven U; Arnold D; Lang-Welzenbach M; Raab HR; Sülberg H; Wittekind C; Potapov S; Staib L; Hess C; Weigang-Köhler K; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R;
Lancet Oncol; 2012 Jul; 13(7):679-87. PubMed ID: 22627104
[TBL] [Abstract][Full Text] [Related]
31. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
[TBL] [Abstract][Full Text] [Related]
32. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Cafiero F; Gipponi M; Lionetto R;
J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
34. Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.
Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Peng J; Ren D; Wang J
J Clin Oncol; 2016 Sep; 34(27):3300-7. PubMed ID: 27480145
[TBL] [Abstract][Full Text] [Related]
35. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma.
Grann A; Feng C; Wong D; Saltz L; Paty PP; Guillem JG; Cohen AM; Minsky BD
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):987-95. PubMed ID: 11240239
[TBL] [Abstract][Full Text] [Related]
36. High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.
Wolff HA; Gaedcke J; Jung K; Hermann RM; Rothe H; Schirmer M; Liersch T; Herrmann MKA; Hennies S; Rave-Fränk M; Hess CF; Christiansen H
Strahlenther Onkol; 2010 Jan; 186(1):30-35. PubMed ID: 20082185
[TBL] [Abstract][Full Text] [Related]
37. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
38. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
40. [Preoperative radiochemotherapy in primary non-resectable rectal cancer].
Keilholz L; Dworak O; Dunst J; Köckerling F; Schwarz B; Sauer R
Strahlenther Onkol; 1995 Feb; 171(2):70-6. PubMed ID: 7863429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]